HIGHLIGHTS
- who: Mengjin Hu and colleagues from the State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China have published the research: Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era, in the Journal: Medicina 2022, 1177 of /2022/
- what: Studies were excluded if they compared the clinical outcomes between different types or dosages of beta-blockers, or if the studies did not focus on patients with AMI.
- how: The results indicated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.